ABBV-744 clinical trial phase 2 data Things To Know Before You Buy
These side effects had been notably milder as compared to an inhibitor of equally bromodomains. An in depth molecular Examination also revealed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen TaylorAchievable new methods for the analysis and treatment of AML. (A) The identification of su